274 related articles for article (PubMed ID: 2952794)
1. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
Tumiati B; Veneziani M; Bellelli A; Portioli I
J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
[No Abstract] [Full Text] [Related]
2. [Chrysotherapy and side effects (author's transl)].
Eberl R
Wien Klin Wochenschr Suppl; 1974; 25():3-22. PubMed ID: 4279096
[No Abstract] [Full Text] [Related]
3. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
Klinefelter
J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
[TBL] [Abstract][Full Text] [Related]
4. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
Svensson A; Theander J
Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
[TBL] [Abstract][Full Text] [Related]
5. Skin testing with gold sodium thiomalate and gold sodium thiosulfate.
Bruze M; Björkner B; Möller H
Contact Dermatitis; 1995 Jan; 32(1):5-8. PubMed ID: 7720377
[TBL] [Abstract][Full Text] [Related]
6. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
7. Oral gold in rheumatoid arthritis.
Drug Ther Bull; 1988 Sep; 26(18):69-72. PubMed ID: 3139386
[No Abstract] [Full Text] [Related]
8. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
[TBL] [Abstract][Full Text] [Related]
9. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
[No Abstract] [Full Text] [Related]
10. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
[TBL] [Abstract][Full Text] [Related]
11. [Against parenteral gold therapy in rheumatoid arthritis].
Kellner H
Dtsch Med Wochenschr; 2011 Aug; 136(33):1677. PubMed ID: 21833892
[No Abstract] [Full Text] [Related]
12. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
14. Scarring alopecia following gold therapy.
Burrows NP; Grant JW; Crisp AJ; Roberts SO
Acta Derm Venereol; 1994 Nov; 74(6):486. PubMed ID: 7701895
[No Abstract] [Full Text] [Related]
15. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.
Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
Inflammation; 1988 Aug; 12(4):373-82. PubMed ID: 3139562
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
Wessel J; Davis P
J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
[No Abstract] [Full Text] [Related]
17. Gold--by mouth?
Symmons D
J Clin Pharm Ther; 1989 Aug; 14(4):243-5. PubMed ID: 2571615
[No Abstract] [Full Text] [Related]
18. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
Harth M; Davis P; Thompson JM; Menard H; Beaudet F
Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
[TBL] [Abstract][Full Text] [Related]
19. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
Lawrence JS
Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
[TBL] [Abstract][Full Text] [Related]
20. Antiarthritic synergism of combined oral and parenteral chrysotherapy. II. Increased inhibition of activated leukocyte oxygen burst by combined gold action.
Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
Inflammation; 1988 Aug; 12(4):383-90. PubMed ID: 2844672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
